January 29, 2015 2:29 AM ET


Company Overview of Indel Therapeutics Inc

Company Overview

Indel Therapeutics Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of antibiotics to address the global health crisis caused by antibiotic resistance. It also grows a pipeline of novel antibiotic drug discovery programs focused on curing difficult to treat and hospital acquired infections. Indel Therapeutics was founded in 2008 and is based in Vancouver, Canada.

4068 West 11th Avenue

Suite 100

Vancouver, BC V6R 2L3


Founded in 2008





Key Executives for Indel Therapeutics Inc

Chief Executive Officer and Director
Executive Chairman
Age: 58
Consulting Vice President of Research
Director of Preclinical Screening
Chairman of the Scientific Advisory Board
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
QSV Biologics, Ltd. Americas
Nanotech Systems Inc. Americas
Intermune Life Sciences, Inc. Americas
AB BioPharma Inc. Americas
Toxin Alert Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Indel Therapeutics Inc, please visit www.indeltherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.